HomeEMCURE • NSE
add
Emcure Pharmaceuticals Ltd
Previous close
₹1,305.95
Day range
₹1,285.70 - ₹1,315.00
Year range
₹1,261.05 - ₹1,408.70
Market cap
245.48B INR
Avg Volume
630.80K
P/E ratio
49.41
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | 16.10B | 15.34% |
Operating expense | 7.60B | 12.23% |
Net income | 1.43B | 31.26% |
Net profit margin | 8.91 | 13.79% |
Earnings per share | — | — |
EBITDA | 3.03B | 22.21% |
Effective tax rate | 26.34% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.42B | — |
Total assets | 67.15B | — |
Total liabilities | 38.01B | — |
Total equity | 29.14B | — |
Shares outstanding | 180.85M | — |
Price to book | 8.59 | — |
Return on assets | 9.08% | — |
Return on capital | 12.01% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | 1.43B | 31.26% |
Cash from operations | 2.77B | 193.00% |
Cash from investing | -574.08M | 45.57% |
Cash from financing | -2.41B | -542.50% |
Net change in cash | -213.27M | -148.86% |
Free cash flow | 1.14B | — |
About
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
Founded
Apr 16, 1981
Website
Employees
11,146
